A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 14, Issue 5, 2001, Pages 245-252

  Kopf, D ^a   Schmitz, H ^a   Beyer, J ^a   Frank, M ^a   Bockisch, A ^a   Lehnert, H ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; INDAPAMIDE; INSULIN; IODOHIPPURATE SODIUM I 131; ISOTOPE; NITRENDIPINE; PENTETATE TECHNETIUM TC 99M; PERINDOPRIL; PLACEBO;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EDEMA; FEMALE; FLUSHING; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MALE; MICROALBUMINURIA; MULTICENTER STUDY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RADIOMETRY; RANDOMIZED CONTROLLED TRIAL; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CREATININE; DIABETIC NEPHROPATHIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; NITRENDIPINE; PERINDOPRIL; PROTEINURIA; TECHNETIUM TC 99M PENTETATE;

EID: 0035667567     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. National High Blood Pressure Education Program Working Group report on hypertension in diabetes
2. The rising tide of endstage renal failure from diabetic nephropathy type II - An epidemiological analysis
3. Renal disease and hypertension in non-insulin-dependent diabetes mellitus
4. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy
5. Clinical features of nephropathy
6. Care of the diabetic patient with end-stage renal disease
7. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
8. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
9. Current strategies for retarding progression of renal disease
10. Pathogenesis, prevention, and treatment of diabetic nephropathy
11. Renal protection in diabetes - An emerging role for calcium antagonists
12. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease
13. The risk of myocardial infarction associated with antihypertensive drug therapies
14. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
15. Calcium channel blockers in diabetic subjects: Innocent at last?
16. Hypertension, microalbuminuria and insulin resistance in diabetes mellitus
17. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria
18. Long-term reduction of microalbuminuria after 3 years of angiotensin-converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients
19. Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy
20. Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes
21. Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria
22. Effect of 1-year treatment with nitrendipine versus enalapril on urinary albumin and alpha 1-microglobulin excretion in microalbuminuric patients with type 1 diabetes mellitus. A randomized, single-blind comparative study
23. Nephroprotective effects of nitrendipine in hypertensive type I and type II diabetic patients
24. Limitations of creatinine as a filtration marker in glomerulopathic patients
25. Laboratory evaluation of renal function
26. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus
27. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment
28. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients
29. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy
30. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment
31. Effects of benazepril and nicardipine on microalbuminuria in normotensive and hypertensive patients with diabetes